Quantcast

Latest Sigma-Aldrich Stories

2014-02-04 20:23:37

RICHMOND, Calif., Feb. 4, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced that the company will release its fourth quarter and full year 2013 financial results on Tuesday, February 11, 2014, after the market closes. The press release will be followed by a conference call at 5:00 p.m. ET, which will be open to the public via telephone and webcast. During the conference call, the company will review the financial results and discuss other business matters....

2014-01-31 16:24:05

ST. LOUIS, Jan. 31, 2014 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and High Technology company, announced they will be presenting at the following investor conferences in February: -- Leerink Swann Global Healthcare Conference 2014 on Thursday, February 13, 2014 in New York City, presenting at 1:50 PM (Eastern). -- 2014 Citi Global Healthcare Conference on Tuesday, February 25, 2014 in New York City, presenting at 1:00 PM...

2014-01-22 08:22:59

St. Louis-based Company Ranked 20th in First-Ever Appearance ST. LOUIS, Jan. 22, 2014 /PRNewswire/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL) was named today for the first time to the "Global 100 Most Sustainable Corporations in the World" list in an announcement made earlier at the World Economic Forum in Davos, Switzerland. The St. Louis-based Company was ranked 20th, one of the highest rankings among its peers. "We are excited and grateful to be named to this year's Global...

2014-01-21 08:22:49

ST. LOUIS, Jan. 21, 2014 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and High Technology Company, today announced the signing of an agreement with Goodfellow Cambridge, Ltd., a leading international supplier of metals and materials for research and industry, to market and distribute Goodfellow's portfolio of materials which includes metals, alloys and ceramics. The agreement expands the availability of Goodfellow's products to new regions...

2014-01-17 08:22:49

ST. LOUIS, Jan. 17, 2014 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced that Sigma Life Science, its innovative biological products and services business, will be launching the genetically-modified HepaRG human liver cell line, licensed from Biopredic, for hepatotoxicity and drug metabolism assays. Currently undergoing beta-testing by multiple contract research and pharmaceutical organizations, the assays will be publicly available later in Q1 2014 in a...

2014-01-15 20:21:39

ST. LOUIS, Jan. 15, 2014 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and High Technology Company, will hold its quarterly conference call to discuss fourth quarter and full-year 2013 financial results on Thursday, February 6, 2014, at 11:00 AM Eastern Time. Conference call details:Date: February 6, 2014 Time: 11:00 AM EST Conference ID#: 34455183 Listen and view the presentation slides via the Internet at http://investor.sigmaaldrich.com/ or...

2014-01-14 23:28:26

Leading graphene-based products manufacturer hires new CEO. Lansing, MI (PRWEB) January 14, 2014 XG Sciences, a leader in the field of graphene and graphene-based products, has named Philip L. Rose as chief executive officer. “We are pleased to welcome Philip to XG Sciences,” said Mike Knox, co-founder and former CEO. “He brings an invaluable combination of scientific and management expertise that will allow him to oversee all aspects of our continued business development. His...

2014-01-09 16:25:05

DUBLIN, January 9, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/tz54gw/european_nuclear) has announced the addition of the "European Radiopharmaceuticals & Stable Isotopes Market 2013-2017" [http://www.researchandmarkets.com/research/tz54gw/european_nuclear ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The therapy market is predominantly driven by its oncologic applications....

2014-01-09 08:27:09

RICHMOND, Calif., Jan. 9, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) will host a teleconference at 8:30 am ET today, Thursday, January 9, 2014, to discuss its global collaboration with Biogen Idec to develop ZFP Therapeutics for hemoglobinopathies. (Logo: http://photos.prnewswire.com/prnh/20130102/SF35903LOGO) A live webcast of the call can be accessed via a link on the Sangamo BioSciences website in the Investor Relations section under Events and...

2014-01-08 08:27:43

RICHMOND, Calif., Jan. 8, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and chief executive officer, will present an update on Sangamo's clinical and preclinical ZFP Therapeutic(®) programs and upcoming milestones, as well as an overview of the Company's business strategy at the 32(nd) Annual J.P. Morgan Healthcare Conference on Thursday, January 16(th) at 11:00 am PT in San Francisco. (Logo:...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.